Inhibiting the AIM2 Pathway Could Potentially Limit Radiation Damage to Cells

New research from Yale University shows that a drug that blocks or inhibits the AIM2 pathway could potentially limit the deleterious side effect of chemotherapy or radiotherapy on cancer patients. High doses of radiation from cancer treatment can cause severe damage to cells and tissues, resulting in injury to bone marrow and the gastrointestinal tract. […]
The post Inhibiting the AIM2 Pathway Could Potentially Limit Radiation Damage to Cells appeared first on SciTech Daily.